The place of newer oral anticoagulants in the treatment of patients with non-valvular atrial fibrillation and coronary artery disease

被引:2
|
作者
McCormack, T. [1 ]
机构
[1] Spring Vale Med Ctr, Whitby YO21 1SD, England
关键词
WARFARIN;
D O I
10.1111/ijcp.12165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With the arrival of the newer oral anticoagulants (NOACs), we now have a more convenient means of providing anticoagulation for patients with non-valvular atrial fibrillation (AF). Are there any particular considerations for the many patients who also have coronary artery disease? For many patients there is an obvious need to use the newer agents but for others, such as those who simply refuse to consider using a vitamin K antagonist (VKA) such as warfarin, the decision may be more problematical.
引用
收藏
页码:707 / 709
页数:3
相关论文
共 50 条
  • [1] Newer Anticoagulants for Non-Valvular Atrial Fibrillation
    Harburger, Joseph M.
    Aronow, Wilbert S.
    PHARMACEUTICALS, 2012, 5 (05) : 469 - 480
  • [2] Novel oral anticoagulants in non-valvular atrial fibrillation
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 115 - 129
  • [3] New oral anticoagulants in non-valvular atrial fibrillation
    Francia P.
    Adduci C.
    Santini D.
    Musumeci B.
    Tocci G.
    High Blood Pressure & Cardiovascular Prevention, 2013, 20 (2) : 53 - 60
  • [4] Oral anticoagulants in diabetic and nondiabetic patients with non-valvular atrial fibrillation
    Derosa, G.
    Raddino, R.
    Gavazzoni, M.
    Pasini, G.
    Gaudio, G.
    Maggi, A.
    D'Angelo, A.
    Ragonesi, P. D.
    Brunetti, N.
    De Gennaro, L.
    Cattaneo, M.
    Maffioli, P.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1409 - 1409
  • [5] Psychological effects of treatment with novel oral anticoagulants in non-valvular atrial fibrillation patients
    Oncel, Can Ramazan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (05): : 364 - 364
  • [6] Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation
    Jolobe, Oscar M. P.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2017, 78 (07) : 416 - 416
  • [7] Use and compliance of treatment with direct oral anticoagulants in non-valvular atrial fibrillation
    Giner-Soriano, M.
    Gomez-Lumbreras, A.
    Cortes, J.
    Morros, R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S27 - S27
  • [8] New anticoagulants in patients with non-valvular atrial fibrillation
    Zellerhoff, S.
    Lewalter, T.
    Eckardt, L.
    Treszl, A.
    Wegscheider, K.
    Breithardt, G.
    NERVENHEILKUNDE, 2012, 31 (11) : 813 - 820
  • [9] Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease
    Lopes, Renato D.
    Steffel, Jan
    Di Fusco, Manuela
    Keshishian, Allison
    Luo, Xuemei
    Li, Xiaoyan
    Masseria, Cristina
    Hamilton, Melissa
    Friend, Keith
    Gupta, Kiran
    Mardekian, Jack
    Pan, Xianying
    Baser, Onur
    Jones, W. Schuyler
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (09): : 1075 - +
  • [10] ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON)
    Derosa, Giuseppe
    Rizzo, Manfredi
    Brunetti, Natale Daniele
    Raddino, Riccardo
    Gavazzoni, Mara
    Pasini, Gianfranco
    Gaudio, Giovanni
    Maggi, Antonio
    D'Angelo, Angela
    De Gennaro, Luisa
    Maffioli, Pamela
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (08)